Cargando…
White coat hypertension in pediatrics
The article summarizes current information on blood pressure changes in children during clinic visit. White coat as a general dressing of physicians and health care personnel has been widely accepted at the end of the 19th century. Two problems can be associated with the use of white coat: white coa...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717664/ https://www.ncbi.nlm.nih.gov/pubmed/26786497 http://dx.doi.org/10.1186/s13052-016-0213-3 |
_version_ | 1782410695394983936 |
---|---|
author | Jurko, Alexander Minarik, Milan Jurko, Tomas Tonhajzerova, Ingrid |
author_facet | Jurko, Alexander Minarik, Milan Jurko, Tomas Tonhajzerova, Ingrid |
author_sort | Jurko, Alexander |
collection | PubMed |
description | The article summarizes current information on blood pressure changes in children during clinic visit. White coat as a general dressing of physicians and health care personnel has been widely accepted at the end of the 19th century. Two problems can be associated with the use of white coat: white coat phenomenon and white coat hypertension. Children often attribute pain and other unpleasant experience to the white coat and refuse afterwards cooperation with examinations. Definition of white coat hypertension in the literature is not uniform. It has been defined as elevated blood pressure in the hospital or clinic with normal blood pressure at home measured during the day by ambulatory blood pressure monitoring system. White coat effect is defined as temporary increase in blood pressure before and during visit in the clinic, regardless what the average daily ambulatory blood pressure values are. Clinical importance of white coat hypertension is mainly because of higher risk for cardiovascular accidents that are dependent on end organ damage (heart, vessels, kidney). Current data do not allow any clear recommendations for the treatment. Pharmacological therapy is usually started in the presence of hypertrophic left ventricle, changes in intimal/medial wall thickness of carotic arteries, microalbuminuria and other cardiovascular risk factors. Nonpharmacological therapy is less controversial and certainly more appropriate. Patients have to change their life style, need to eliminate as much cardiovascular risk factors as possible and sustain a regular blood pressure monitoring. |
format | Online Article Text |
id | pubmed-4717664 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2016 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-47176642016-01-20 White coat hypertension in pediatrics Jurko, Alexander Minarik, Milan Jurko, Tomas Tonhajzerova, Ingrid Ital J Pediatr Review The article summarizes current information on blood pressure changes in children during clinic visit. White coat as a general dressing of physicians and health care personnel has been widely accepted at the end of the 19th century. Two problems can be associated with the use of white coat: white coat phenomenon and white coat hypertension. Children often attribute pain and other unpleasant experience to the white coat and refuse afterwards cooperation with examinations. Definition of white coat hypertension in the literature is not uniform. It has been defined as elevated blood pressure in the hospital or clinic with normal blood pressure at home measured during the day by ambulatory blood pressure monitoring system. White coat effect is defined as temporary increase in blood pressure before and during visit in the clinic, regardless what the average daily ambulatory blood pressure values are. Clinical importance of white coat hypertension is mainly because of higher risk for cardiovascular accidents that are dependent on end organ damage (heart, vessels, kidney). Current data do not allow any clear recommendations for the treatment. Pharmacological therapy is usually started in the presence of hypertrophic left ventricle, changes in intimal/medial wall thickness of carotic arteries, microalbuminuria and other cardiovascular risk factors. Nonpharmacological therapy is less controversial and certainly more appropriate. Patients have to change their life style, need to eliminate as much cardiovascular risk factors as possible and sustain a regular blood pressure monitoring. BioMed Central 2016-01-15 /pmc/articles/PMC4717664/ /pubmed/26786497 http://dx.doi.org/10.1186/s13052-016-0213-3 Text en © Jurko et al. 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated. |
spellingShingle | Review Jurko, Alexander Minarik, Milan Jurko, Tomas Tonhajzerova, Ingrid White coat hypertension in pediatrics |
title | White coat hypertension in pediatrics |
title_full | White coat hypertension in pediatrics |
title_fullStr | White coat hypertension in pediatrics |
title_full_unstemmed | White coat hypertension in pediatrics |
title_short | White coat hypertension in pediatrics |
title_sort | white coat hypertension in pediatrics |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4717664/ https://www.ncbi.nlm.nih.gov/pubmed/26786497 http://dx.doi.org/10.1186/s13052-016-0213-3 |
work_keys_str_mv | AT jurkoalexander whitecoathypertensioninpediatrics AT minarikmilan whitecoathypertensioninpediatrics AT jurkotomas whitecoathypertensioninpediatrics AT tonhajzerovaingrid whitecoathypertensioninpediatrics |